Elst, The Netherlands, 8 July 2025 – Artinis Medical Systems, a pioneer in functional Near-Infrared Spectroscopy (fNIRS), is pleased to announce a strategic partnership with NIRx Medical Technologies. With the support of healthcare investor Gilde Healthcare, this collaboration marks a significant milestone in Artinis’ mission to advance neuroscience through accessible, high-impact neuroimaging solutions.

This partnership brings together two world-leading fNIRS innovators, aligned around a shared vision to accelerate brain imaging innovation and broaden global access to cutting-edge research tools. Artinis will continue to operate under its own name, from its existing location.

By joining forces, Artinis will benefit from combined scale and complementary strengths, allowing for greater investment in R&D, expanded sales and support capacity, and a broader reach across both basic and applied neuroscience. Leadership continuity is ensured, with Willy Colier and Marianne Floor continuing to lead Artinis, and Patrick Britz and Mylène Henry heading NIRx. Together, they are part of the new group’s leadership team.

Dr. Willy Colier, co-founder and CEO of Artinis: "Roeland, my co-founder, and I are proud of Artinis' journey over the past 24 years. We have built a company known for its great products, fantastic people, and satisfied customers. Joining forces with NIRx is an exciting step that will enhance the value we provide to both our current and future customers. We look forward to this new phase as we leverage our combined scale and expertise, benefiting from the support of Gilde Healthcare."

Dr. Patrick Britz, CEO of NIRx, added: "Constant innovation has made functional near-infrared spectroscopy a rapidly growing and highly productive solution for neuroscience. Now, with the strong support of Gilde Healthcare, two highly skilled teams, NIRx and Artinis, are joining forces to accelerate these advancements. I am genuinely thrilled about the possibilities this partnership unlocks, fNIRS is just at its beginning."

This partnership strengthens Artinis’ ability to support researchers in unlocking deeper insights into the human brain more accurately, effectively, and accessibly while continuing to invest in its people and values.

Completion of the transaction is subject to regulatory approval.

Featured

Artinis and NIRx join forces to accelerate innovation in brain imaging

Artinis Medical Systems, a pioneer in functional Near-Infrared Spectroscopy (fNIRS), is pleased to announce a strategic partnership with NIRx Medical Technologies. With the support of healthcare investor Gilde Healthcare, this collaboration marks a significant milestone in Artinis’ mission to advance neuroscience through accessible, high-impact neuroimaging solutions.

Publication overview 2024 - fNIRS studies with our devices

In 2024, an increasing number of relevant literature measuring brain activity with our fNIRS devices have been published. In this blogpost, we discuss application fields and purposes of using fNIRS to measure in the brain, and highlight exciting studies published in the last year with Artinis devices per category. Further, we show recent publications using our devices in naturalistic settings outside of the lab.

Announcing Artinis’ Acquisition of TMSi: A Strategic Partnership

We are proud to announce that Artinis has acquired TMSi. This acquisition allows both companies to leverage over two decades of combined expertise and technology, enabling us to offer even more advanced solutions for the medical and scientific markets.

Publication overview 2023: Using our (f)NIRS devices to measure in the brain

We are proud that in 2023 an increasing number of publications using our (f)NIRS devices to measure brain activity could be found. In this blogpost, we list application areas with papers released last year utilizing our devices. We also highlight and summarize interesting publications per application category.

Publication Overview with our NIRS devices in 2022 – Brain

We are proud that several papers using our (f)NIRS devices to measure brain activation from different cortical areas and in various application fields were published in 2022. Read this blogpost to get an overview of application areas (f)NIRS can be used in, and which devices can be applied. Also, find highlighted publications per category that were performed with our devices in 2022.

Assessing NIRS signal quality – Implementation of the Signal Quality Index (SQI)

Achieving good signal quality is crucial for (f)NIRS data acquisition and analysis, but often difficult to determine. Therefore, we developed an algorithm named SQI (Signal Quality Index) which rates NIRS signal quality. Read this blogpost to learn more on how this SQI is specified and how it can be implemented in your research.

Using fNIRS to measure brain activity on the field during penalty kicks – a video interview with Max Slutter

fNIRS is increasingly used in on-the-field studies. One of the first to perform such a study by measuring brain activity with fNIRS in football players during penalty kicks were Max Slutter and colleagues. Watch our new video interview with Max Slutter to learn more about performing research with fNIRS on the field, and the advantages, but also challenges this might bring with it.

Combining Virtual Reality and wearable fNIRS

The application of Virtual Reality (VR) is becoming increasingly important in clinical and psychological research, for instance in exposure therapy or neurorehabilitation. fNIRS can be used to monitor brain activity during application of VR. We tested simultaneous use of VR and fNIRS with our new device, the Brite Frontal. Read in this blogpost, how this went and which advantages using fNIRS during VR application can demonstrate.

Artinis and NIRx join forces to accelerate innovation in brain imaging

Motion artefacts in (f)NIRS — Not a problem, but not to be overlooked